353 related articles for article (PubMed ID: 28684903)
1. Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients.
Ruan W; Wu M; Shi L; Li F; Dong L; Qiu Y; Wu X; Ying K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1775-1780. PubMed ID: 28684903
[TBL] [Abstract][Full Text] [Related]
2. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
[TBL] [Abstract][Full Text] [Related]
5. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP
Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888
[TBL] [Abstract][Full Text] [Related]
9. Expression and Clinical Significance of Serum Dipeptidyl Peptidase IV Chronic Obstructive Pulmonary Disease.
Chang XY; Yang Y; Jia XQ; Wang Y; Peng LN; Ai XH; Jiang CY; Guo JH; Wu TT
Am J Med Sci; 2016 Mar; 351(3):244-52. PubMed ID: 26992252
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
[TBL] [Abstract][Full Text] [Related]
11. Progranulin is a novel biomarker for predicting an acute exacerbation of chronic obstructive pulmonary disease.
Chen X; Liu J; Zhu M; Hu B; Bai F; Jin W; Zhou J; Chen C; Song Y; Pan J
Clin Respir J; 2018 Oct; 12(10):2525-2533. PubMed ID: 30099848
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil CD64 Expression as a Diagnostic Marker in Patients Hospitalized with Exacerbations of COPD: A Prospective Observational Study.
Titova E; Aune MW; Fonn K; Henriksen AH; Åsberg A
Lung; 2015 Oct; 193(5):717-24. PubMed ID: 26174093
[TBL] [Abstract][Full Text] [Related]
13. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction.
Adrish M; Nannaka VB; Cano EJ; Bajantri B; Diaz-Fuentes G
Int J Chron Obstruct Pulmon Dis; 2017; 12():1183-1189. PubMed ID: 28458528
[TBL] [Abstract][Full Text] [Related]
14. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
15. Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Wang Y; Fei J; Xu J; Cheng ZY; Ma YC; Wu JH; Yang J; Zhao H; Fu L
Lung; 2024 Jun; 202(3):245-255. PubMed ID: 38743087
[TBL] [Abstract][Full Text] [Related]
16. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD.
Hsu CW; Suk CW; Hsu YP; Chang JH; Liu CT; Huang SK; Hsu SC
Respir Res; 2022 Mar; 23(1):63. PubMed ID: 35307030
[TBL] [Abstract][Full Text] [Related]
18. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
COPD; 2016; 13(2):139-45. PubMed ID: 26514682
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
20. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
